PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
The British Snack Co makes quirky and original British snacks. The company's award-winning flavours and unique ranges of craft popcorn, crisps, and pork snacks have sold over 8 million bags to date. It aims to be a contender in the £3.2 billion UK snacks market. The company's products are stocked across major retailers like Waitrose, Ocado's, Morrisons, Borough Box, and Amazon, to name a few. Its craft pork scratching product, Awfully Posh, was the first pork snack ever to win a Great Taste Award. The company has been working with buyers in the hospitality industry to create joint marketing plans for after lockdown to rapidly grow its Out Of Home (OOH) sales. It will use 50% of the investment to grow its staff, 37.5% towards trade marketing, and 12.5% for New Product Development (NPD).
days to go:
Expired
investment:
£382,495
Raw Holo is an award-winning company, making organic raw chocolate bars with natural plant-based ingredients flavoured with coconut sugar. Its bars are wrapped in 100% recyclable, plastic-free packaging. The company has acquired national listings with Waitrose and Holland & Barrett in Feb 2019 and, sold 1 million bars till date. Its product is available in 1000+ stores in Ireland and Uk. The company will use the funds to launch into new major retailers, build the brand with creative marketing campaigns and grow the sales team.
days to go:
Expired
investment:
£157,590
Bird and Blend Tea (BABT) is a British independent tea mixologist. The company claims to offer 100+ blends of tea in a vegan-friendly product range, employs 125+ people and runs a global e-commerce platform attracting 100,000 monthly users. It claims to have achieved a £3.97 million turnover in 2020-2021 despite lockdown closures of its retail stores. BABT asserts that it operates 13 experiential retail stores across the UK since its last crowdfund in 2017. It has also featured in press entities such as The Independent, OK!, Huff Post, The Telegraph, and GQ Magazine. The company states it will use the investment to expedite the growth of its brand with investments in digital innovation, develop its technology stack, strengthen its team, open more multisensory stores, and undertake impactful projects to achieve B Corp status.
days to go:
Expired
investment:
£999,867
Grubby is a purpose-led recipe kit brand on a mission to make plant-based cooking more accessible without damaging the earth. It argues that there has been a 400% increase in people moving to a plant-based diet from 2014 to 2019. It intends to cater to this demand. The company asserts that it is a 100% plant-based business and intends to combine three rapidly growing areas namely, food delivery, meal kits, and plant-based diets. It also wants to become a contender in the recipe kits market that has experienced a £385 million growth since 2015. Grubby has served over 50,000 meals since its launch, received 100+ 5-star reviews, and grown sales 130% in the last quarter to £135,000. It has received investment from angel investors including founders of Skyscanner and World First. Grubby will use the investment to continue its growth through product innovation, speciality add-ons, and an enhanced digital experience to boost customer acquisition.
days to go:
Expired
investment:
£1,049,472
OXTO Energy is an energy storage technology provider that intends to transform the way energy is stored. It claims to have developed an innovative energy storage flywheel technology made using 100% recyclable steel, having a low cost of operation, and being easy to manufacture. It argues that it has secured approximately £1.7 million worth of revenues through contracts for 2021 in UK, Kenya, and France, to name a few. It also aspires to become a minority partner of large infrastructure projects by offering its units at a discounted rate, guaranteeing a consistent revenue stream while increasing profitability throughout the project. It wants to dominate the estimated £70 billion energy storage market. The company states it will use 25% of the investment to grow its team, 60% for project delivery, and 15% towards growth and commercialisation of its business.
days to go:
Expired
investment:
£635,493
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
